Stay updated on Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Sign up to get notified when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.

Latest updates to the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page
- Check3 days agoChange DetectedNo significant changes were observed on the study details page between the two screenshots.SummaryDifference0.1%

- Check10 days agoChange DetectedNo substantive changes to core study content (design, eligibility criteria, enrollment, primary or secondary outcomes, or locations) were observed; the update appears to be metadata such as the last update date. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoChange DetectedNo significant additions or deletions were observed on the Study Details page; the content and purpose remain unchanged.SummaryDifference0.2%

- Check39 days agoChange DetectedSummary of changes: added a prominent notice about funding and operating status and updated the revision from v3.1.0 to v3.2.0.SummaryDifference2%

- Check46 days agoChange DetectedMajor change: page now shows Revision: v3.1.0 and removes several drug-safety topics; indicates a content reorganization with updated versioning rather than new substantive information in the deleted areas.SummaryDifference0.3%

- Check60 days agoChange DetectedUpdated the page to Revision: v3.0.2 and removed the 'Back to Top' element. No other substantive changes to core content are evident.SummaryDifference0.1%

Stay in the know with updates to Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.